Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance
Michael S Gold, Jim Buttery, Peter McIntyre
Sexual Health | CSIRO PUBLISHING | Published : 2010
MG was a member of ADRAC from 2006 to 2009 and was member of the NSW HPV expert panel. MG has made presentations at meetings on HPV vaccine safety that have been funded by CSL. JB has served on an advisory board for GlaxkoSmithKline (GSK) and serves on a data safety monitoring board for CSL. The Murdoch Children's Research Institute (MCRI) receives reimbursement from both GSK and CSL for JB's attendance at advisory board and scientific meetings. MCRI receives in kind support from Merck for HPV serology assays. PM was member of the NSW HPV expert panel and the TGA Gardasil expert panel. PM is director of the National Centre for Immunisation Research and Surveillance (NCIRS) and this centre holds funding agreements with Department of Health and Ageing and NSW Health, and the NCIRS receives in kind support from Merck for HPV serological study and from GSK for a neonatal pertussis study.